header logo image

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

January 12th, 2021 3:53 am

Lille, France; Cambridge, MA; January 11, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial.

Follow this link:
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick